Phibro Animal Health Corporation ( PAHC) - Key Metrics
PAHC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | $9.22 | $0.68 | ? | ? |
| 2026Q1 | $8.98 | $0.65 | $0.23 | -$0.11 |
| 2025Q4 | $9.35 | $0.43 | $0.53 | $0.20 |
| 2025Q3 | $8.59 | $0.52 | $1.07 | $0.87 |
PAHC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | 17.71% | 13.79 |
| 2026Q1 | 18.34% | 15.46 |
| 2025Q4 | 28.24% | 15.01 |
| 2025Q3 | 23.30% | 10.36 |
PAHC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 0.04% | ? |
| 2026Q2 | 0.55% | 0.32% |
| 2026Q1 | -0.27% | 0.30% |
| 2025Q4 | 0.79% | 0.47% |
| 2025Q3 | 4.09% | 0.56% |
PAHC
Price: $32.07
Dividend Yield: 1.45%
Forward Dividend Yield: 1.50%
Payout Ratio: 800.00%
Dividend Per Share: 0.48 USD
Earnings Per Share: 2.33 USD
P/E Ratio: 15.59
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 51500
Ebitda: 30.9 millionMarket Capitalization: 1.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR10: 1.93%